Evaluation of nonprescription syringe sales in San Francisco

Journal of the American Pharmacists Association

Volumn 50, Issue 5, 2010, Pages 595-599

  Rose, Valerie J ^a,b   Raymond, H Fisher ^c  

^a Public and Community Health Consulting   (United States)

^b SAN JOSE STATE UNIVERSITY   (United States)

^c AIDS Office San Francisco   (United States)

Author keywords

California; Injection drug users; Nonprescription syringe sales; Pharmacy services

Indexed keywords

NON PRESCRIPTION DRUG;

ARTICLE; COMMERCIAL PHENOMENA; ECONOMICS; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MALE; NEEDLE; PATIENT EDUCATION; PHARMACIST; PHARMACY; SUBSTANCE ABUSE; SYRINGE; TIME MANAGEMENT; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; COMMERCE; DATA COLLECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; NEEDLES; NONPRESCRIPTION DRUGS; PATIENT EDUCATION AS TOPIC; PHARMACIES; PHARMACISTS; SAN FRANCISCO; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; TIME MANAGEMENT;

EID: 79952778741     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.09033     Document Type: Article

References (26)

1. California Department of Public Health, Office of AIDS. California syringe access: SB 1159 resource library. Accessed at www.syringeaccess.com, October 20, 2008.
2. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-14.
3. California Department of Public Health, Office of AIDS. Cumulative AIDS case data through September 30, 2008. Accessed at www.cdph.ca.gov/data/ statistics/Documents/OA-2008-09-AIDSMerged.pdf, November 30, 2008.
4. San Francisco Department of Public Health. Quarterly AIDS surveillance report through June, 2008. Accessed at http://sfhiv.org/files/data-reports/aids- surv-quart-rpt/qrpt0608.pdf, October 1, 2008.
5. Stopka TJ, Garfein RS, Ross A, Truax SR. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health. 2006;84:116-25.
6. Auerbach CF. Qualitative data: an introduction to coding and analysis. Accessed at http://site.ebrary.com.libaccess.sjlibrary. org/lib/sjsu/Doc?id= 10078435&ppg=117, May 22, 2009.
7. San Francisco Police Department. Crime maps. Accessed at http://gispubweb.sfgov.org/website/san-francisco-community/ wizard.asp, May 15, 2009.
8. Vorobjob S, Uusküla A, Abel-Ollo K, et al. Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm Reduct J. 2009;6:3.
9. Moatti JP, Vlahov, D, Feroni I, et al. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and pharmacy sales in Marseille, France. Eur Addict Res. 2001;7:40-5.
10. Rich JD, Martin EG, Macalino GE, et al. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc. 2002;42(6 suppl 2):S58-61.
11. Lewis BA, Koester SK, Bush TW. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc. 2002;42(6 Suppl 2):S46-51.
12. Taussig J, Junge B, Burris S, et al. Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc. 2002;42(6 Suppl 2):S40-5.
13. Heimer R, Clair S, Teng W, et al. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001. J Urban Health. 2002;79:555-70.
14. Klein SJ, Harris-Valente K, Candelas AR, et al. What do pharmacists think about New York State's new nonprescription syringe sale program? Results of a survey. J Urban Health. 2001;78:679-89.
15. Linas BP, Coffin PO, Backes G, Vlahov D. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation. J Urban Health. 2000;77:768-80.
16. Farley TA, Niccolai LM, Billeter M, et al. Attitudes and practices of pharmacy managers regarding needle sales to injection drug users. J Am Pharm Assoc. 1999;39:23-6.
17. Case P, Beckett G, Jones S. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(1 suppl):S94-101.
18. Gleghorn AA, Gee G, Vlahov D. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(1 suppl):S89-93.
19. Fuller CM, Galea S, Caceres W, et al. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007;97:117-24.
20. Tesoriero JM, Battles HB, Klein SJ, et al. Expanding access to sterile syringes through pharmacies: assessment of New York's expanded syringe access program. J Am Pharm Assoc. 2009;49:407-16.
21. Deibert RJ, Goldbaum G, Parker TR, et al. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003. Am J Public Health. 2006;96:1347-58.
22. Pouget ER, Deren S, Fuller CM, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State expanded syringe access demonstration program. J Acquir Immune Defic Syndr. 2005;39:471-7.
23. Bluthenthal RN, Malik MR, Grau LE, et al. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004;99:1136-46.
24. Fuller CM, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc. 2002;42(6 suppl 2):S77-82.
25. Cotton-Oldenburg NU, Carr P, DeBoer JM, et al. The Minnesota Pharmacy Syringe Access Initiative: a successful statewide program to increase injection drug user access to sterile syringes. J Am Pharm Assoc. 2002;42(6 Suppl 2):S21-2.
26. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers: Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:82-9.